Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Galena Biopharma Inc    GALE   US3632561086

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
05/18/2015 05/19/2015 05/20/2015 05/21/2015 05/22/2015 Date
1.31(c) 1.3(c) 1.3(c) 1.33(c) 1.36 Last
2 264 713 1 648 753 1 421 847 1 493 372 3 210 914 Volume
-2.96% -0.76% 0.00% +2.31% +2.26% Change
More quotes
Financials ($)
Sales 2015 16,1 M
EBIT 2015 -44,6 M
Net income 2015 -46,5 M
Debt 2015 -
Yield 2015 -
Sales 2016 27,5 M
EBIT 2016 -35,6 M
Net income 2016 -34,5 M
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 13,4x
Capi. / Sales 2016 7,83x
Capitalization 215 M
More Financials
Company
Galena Biopharma, Inc. is a biotechnology company focused on discovering, developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care.Its development portfolio ranges from mid to late stage clinical assets which include... 
Sector
Pharmaceuticals
Calendar
06/19Shareholder meeting
More about the company
Surperformance© ratings of Galena Biopharma Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on GALENA BIOPHARMA INC
07:05a GALENA BIOPHARMA : to Present GALE-401 (Anagrelide Controlled Release) Phase 2 C..
05/08 GALENA BIOPHARMA : Reports First Quarter 2015 Financial Results
05/07 GALENA BIOPHARMA : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION A..
05/07 GALENA BIOPHARMA : Results of Operations and Financial Condition, Financial Stat..
05/07 Galena Biopharma Reports First Quarter 2015 Financial Results
04/25 GALENA BIOPHARMA : Notice of Summons and Complaint Against Defendants Milla Bjor..
04/23 GALENA BIOPHARMA : to Report First Quarter Financial Results on Thursday, May 7,..
04/23 Galena Biopharma to Report First Quarter Financial Results on Thursday, May 7..
More news
Sector news : Pharmaceuticals - NEC
05:29p AMGEN : ends work on experimental psoriasis drug
05:26pDJAmgen Ends Psoriasis-Drug Partnership With AstraZeneca
05:13p TSX eases after recent rally as energy, financials slip
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
05/07 Galena Biopharma's (GALE) CEO Mark Schwartz on Q1 2015 Results - Earnings Cal..
05/06 Notable earnings after Thursday?s close
05/01 NEXT WEEK IN BIOTECH : Earnings Deluge - From GSK And Achillion To Intercept And..
04/24 SEEKING ALPHA'S BIOTECH WEEKLY : Gilead Isn't Perfect, Biogen-Bass, Spring Fever..
04/22 Galena Biopharma Is A Worthwhile Gamble For The Short Or Long Term


Comments 
Advertisement
Chart GALENA BIOPHARMA INC
Duration : Period :
Galena Biopharma Inc Technical Analysis Chart | GALE | US3632561086 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions